These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


59 related items for PubMed ID: 4024035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA, Groeneveld E, Rijken DC.
    Thromb Haemost; 1993 Sep 01; 70(3):481-5. PubMed ID: 8259553
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The contamination with coagulative substance in urokinase preparation (author's transl)].
    Shiba T, Igarashi M, Hirose K, Takeuchi S, Awazu S, Asada T.
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun 01; 42(3):537-40. PubMed ID: 495012
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preparation (agar zone electrophoresis) and immunological characterisation of urokinase.
    Andrassy K, Ritz E.
    Thromb Haemost; 1977 Aug 31; 38(2):536-44. PubMed ID: 579494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Possible use of monoclonal antibodies to standardize the production and use of human urokinase.
    Harris WJ, Weston J, Gilmour J, Hart H.
    Dev Biol Stand; 1984 Aug 31; 57():349-54. PubMed ID: 6543201
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of high molecular weight urokinase and low molecular weight urokinase.
    Nobuhara M, Sakamaki M, Ohnishi H, Suzuki Y.
    J Biochem; 1981 Jul 31; 90(1):225-32. PubMed ID: 7026550
    [Abstract] [Full Text] [Related]

  • 13. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME, Rijken DC, Groeneveld E, van Berkel TJ, Kuiper J.
    Thromb Haemost; 1995 Aug 31; 74(2):722-9. PubMed ID: 8585013
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunochemical studies of high and low molecular forms of urokinase.
    Sumi H, Toki N, Maehara S, Kosugi T, Akazawa K, Matsuo O, Mihara H.
    Acta Haematol; 1982 Aug 31; 67(4):263-7. PubMed ID: 6810625
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE, Gow L, Campbell DM, Ogston D.
    Thromb Haemost; 1983 Feb 28; 49(1):21-3. PubMed ID: 6221434
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.